Bacopa monnieri Reference

Plain English

What it is

Bacopa monnieri (also called Brahmi) is a plant used for a long time in Ayurvedic (traditional Indian) medicine. In the US it is sold as a dietary supplement, not as an FDA-approved drug.

What people use it for

People take it as a slow-building memory and focus aid, hoping it helps recall and learning over weeks rather than working right away.

What the science shows

Several human studies and research reviews point to small, gradual gains in things like attention speed and memory, but the results are mixed and the benefits are modest, not dramatic. It is not a proven treatment for dementia, ADHD, or any diagnosed condition.

The catch

Any effect builds slowly over weeks and tends to be minor. Stomach upset such as nausea, cramps, and more frequent stools is the most common complaint, and the long-term safety of larger amounts is not well known. Different extracts are not the same strength, so products vary.

Reference summary

Bacopa has a long Ayurvedic tradition for 'medhya rasayana' (memory tonic) use. Modern human evidence is moderate for a botanical: multiple 8-12 week randomized trials in healthy adults and older adults (Stough 2001, Calabrese 2008, Morgan 2010, Roodenrys 2002) and a 2014 meta-analysis suggest small but reproducible improvements in delayed recall, learning rate, and information-processing speed, with effect sizes smaller than prescription cognitive enhancers. Pediatric ADHD-symptom trials are smaller and lower quality. Mechanistically, bacosides modulate cholinergic and serotonergic signaling, support BDNF expression, and act as antioxidants; rodent models also show dendritic-arborization changes that have not been demonstrated in humans.

Regulatory and posture

Categories

Nootropic, Cognitive

Aliases

Brahmi, Water hyssop, Bacognize, BacoMind, CDRI 08, KeenMind

Evidence posture

human - Sold as a dietary supplement, not as an FDA-approved drug. Effects on cognition are reported across multiple small trials; full effect requires 8-12 weeks of continuous use, and benefits are modest rather than dramatic. Not a treatment for dementia, ADHD, or any other diagnosed condition.

Regulatory status

No FDA-approved Bacopa drug label. Used for centuries in Ayurvedic medicine and sold in the US as a dietary supplement, typically standardized to 20-55 percent bacosides (Bacognize is a 12 percent standardization with a distinct extract profile; CDRI 08 / KeenMind is the most heavily studied standardization). Different extracts are not interchangeable on a per-milligram basis.

Content review status

research reference